Thermo Fisher Scientific Overview

  • Year Founded
  • 1956

Year Founded

  • Status
  • Public

  • Employees
  • 125,000

Employees

  • Stock Symbol
  • TMO

Stock Symbol

  • Investments
  • 102

  • Share Price
  • $405.08
  • (As of Monday Closing)

Thermo Fisher Scientific General Information

Description

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).

Contact Information

Formerly Known As
Fisher Scientific International, Scientific Materials Company, Thermo Electron
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 168 Third Avenue
  • Waltham, MA 02451
  • United States
+1 (781)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Laboratory Services (Healthcare)
Discovery Tools (Healthcare)
Stock Exchange
NYS
Corporate Office
  • 168 Third Avenue
  • Waltham, MA 02451
  • United States
+1 (781)

Thermo Fisher Scientific Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thermo Fisher Scientific Stock Performance

As of 16-Jun-2025, Thermo Fisher Scientific’s stock price is $405.08. Its current market cap is $153B with 377M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$405.08 $402.76 $390.50 - $627.88 $153B 377M 2.62M $17.09

Thermo Fisher Scientific Financials Summary

As of 31-Mar-2025, Thermo Fisher Scientific has a trailing 12-month revenue of $42.9B.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 213,517,164 227,763,113 234,351,564 242,397,171
Revenue 42,898,000 42,879,000 42,857,000 44,915,000
EBITDA 10,373,000 10,457,000 10,200,000 11,670,000
Net Income 6,515,000 6,335,000 5,995,000 6,950,000
Total Assets 99,041,000 97,321,000 98,726,000 97,154,000
Total Debt 34,189,000 31,275,000 34,917,000 34,488,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Thermo Fisher Scientific Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Thermo Fisher Scientific‘s full profile, request access.

Request a free trial

Thermo Fisher Scientific Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life scienc
Diagnostic Equipment
Waltham, MA
125,000 As of 2024

Hercules, CA
 

Billerica, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Thermo Fisher Scientific Competitors (10)

One of Thermo Fisher Scientific’s 10 competitors is Bio-Rad Laboratories, a Corporation company based in Hercules, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bio-Rad Laboratories Corporation Hercules, CA
Bruker Formerly VC-backed Billerica, MA
Sysmex (Diagnostic Equipment) Corporation Kobe, Japan
GE HealthCare Technologies Corporation Chicago, IL
Harvard Bioscience Formerly PE-Backed Holliston, MA
You’re viewing 5 of 10 competitors. Get the full list »

Thermo Fisher Scientific Patents

Thermo Fisher Scientific Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202505111-D0 Mass spectrometry Pending 04-Apr-2025
GB-202503759-D0 Miniature multipole Pending 14-Mar-2025
GB-202503521-D0 A multipole mass analyzer Pending 11-Mar-2025
GB-202503315-D0 Analytical instrument calibration and health check Pending 07-Mar-2025
GB-202503313-D0 Analytical instrument health check Pending 07-Mar-2025
To view Thermo Fisher Scientific’s complete patent history, request access »

Thermo Fisher Scientific Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thermo Fisher Scientific Investments & Acquisitions (102)

Thermo Fisher Scientific’s most recent deal was a Merger/Acquisition with Solventum (Purification and Filtration Business) for . The deal was made on 25-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Solventum (Purification and Filtration Business) 25-Feb-2025 Merger/Acquisition Other Commercial Services
miDiagnostics 04-Dec-2024 Later Stage VC Diagnostic Equipment
CytoReason 15-Jul-2024 Later Stage VC Discovery Tools (Healthcare)
Olink Proteomics 10-Jul-2024 Merger/Acquisition Discovery Tools (Healthcare)
CorEvitas 14-Aug-2023 Merger/Acquisition Consulting Services (B2B)
You’re viewing 5 of 102 investments and acquisitions. Get the full list »

Thermo Fisher Scientific ESG

Risk Overview

Risk Rating

Updated March, 12, 2025

11.86 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,673

Rank

Percentile

Pharmaceuticals

Industry

of 844

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 59

Rank

Percentile

To view Thermo Fisher Scientific’s complete esg history, request access »

Thermo Fisher Scientific Exits (11)

Thermo Fisher Scientific’s most recent exit was on 11-May-2022 from Ionpath. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Ionpath 11-May-2022 Completed
Novasep Belgium 15-Jan-2021 Completed
Arranta Bio 30-Oct-2019 Completed
  • 3 buyers
Coriell Life Sciences 06-May-2019 Completed
Yourgene Health 17-Feb-2019 PIPE Completed
You’re viewing 5 of 11 exits. Get the full list »

Thermo Fisher Scientific Affiliates

Subsidiaries (16)

Name Industry Location Year Founded
MarqMetrix Seattle, WA 2012
Olink Proteomics Uppsala, Sweden 2004
CorEvitas Waltham, MA 2001
eBioscience San Diego, CA 1999
BioImage Soborg, Denmark 1999
You’re viewing 5 of 16 affiliates. Get the full list.  »

Thermo Fisher Scientific FAQs

  • When was Thermo Fisher Scientific founded?

    Thermo Fisher Scientific was founded in 1956.

  • Where is Thermo Fisher Scientific headquartered?

    Thermo Fisher Scientific is headquartered in Waltham, MA.

  • What is the size of Thermo Fisher Scientific?

    Thermo Fisher Scientific has 125,000 total employees.

  • What industry is Thermo Fisher Scientific in?

    Thermo Fisher Scientific’s primary industry is Diagnostic Equipment.

  • Is Thermo Fisher Scientific a private or public company?

    Thermo Fisher Scientific is a Public company.

  • What is Thermo Fisher Scientific’s stock symbol?

    The ticker symbol for Thermo Fisher Scientific is TMO.

  • What is the current stock price of Thermo Fisher Scientific?

    As of 16-Jun-2025 the stock price of Thermo Fisher Scientific is $405.08.

  • What is the current market cap of Thermo Fisher Scientific?

    The current market capitalization of Thermo Fisher Scientific is $153B.

  • What is Thermo Fisher Scientific’s current revenue?

    The trailing twelve month revenue for Thermo Fisher Scientific is $42.9B.

  • Who are Thermo Fisher Scientific’s competitors?

    Bio-Rad Laboratories, Bruker, Sysmex (Diagnostic Equipment), GE HealthCare Technologies, and Harvard Bioscience are some of the 10 competitors of Thermo Fisher Scientific.

  • What is Thermo Fisher Scientific’s annual earnings per share (EPS)?

    Thermo Fisher Scientific’s EPS for 12 months was $17.09.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »